Get the tools used by (smart)2 investors.

Unadjusted EBITDA for Zynex Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ZYXI: Zynex Inc

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with elec...

- USD
Price
USD
Fair Value
Upside
- - -
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Zynex Inc's Unadjusted EBITDA:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240 K10 M20 M30 M

Performance Summary
  • Zynex's latest twelve months unadjusted ebitda is 10.791 million
  • Zynex's unadjusted ebitda for fiscal years ending December 2020 to 2024 averaged 18.193 million.
  • Zynex's operated at median unadjusted ebitda of 17.893 million from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Zynex's unadjusted ebitda peaked in December 2022 at 25.884 million.
  • Zynex's unadjusted ebitda hit its 5-year low in December 2024 of 10.791 million.
  • Zynex's unadjusted ebitda decreased in 2020 (11.744 million, -7.7%), 2023 (17.893 million, -30.9%), and 2024 (10.791 million, -39.7%) and increased in 2021 (24.652 million, +109.9%) and 2022 (25.884 million, +5.0%).

How does Zynex's Unadjusted EBITDA benchmark against competitors?

Hide this widget

Metric Usage: Unadjusted EBITDA

Hide this widget
ebitda_unadj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Unadjusted EBITDA in the financials category include:

  • Weighted Average Diluted Shares Out. - The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
  • Shares per Depository Receipt - ADR/GDR ratio for all companies that are deemed the ADR/GDR security as company primary (all non-primary ADR/GDR companies will be given a value = 1)
  • Total Assets - The sum of all assets on a company's balance sheet.
  • Accumulated Depreciation - This item represents the year-end accumulated balance of amounts provided as depreciation on property, plant and equipment till the current year.
View Full List

Search for metric or datapoint

Unadjusted EBITDA

Unadjusted income before interest, taxes, depreciation and amortization.

Definition of Unadjusted EBITDA

Hide this widget

Unadjusted EBITDA for Zynex is calculated as follows:

Earnings Before Taxes [ 3.627 M ]
(+) Net Interest Expenses [ 2.382 M ]
(+) Non Operating Expenses [ zero ]
(+) Depreciation and Amortization [ 4.782 M ]

(=) Unadjusted EBITDA [ 10.791 M ]

Unadjusted EBITDA is defined as Earnings before Interest, Taxes, Depreciation and Amortization. This metric does not adjust for unusual items.

It is a commonly used metric in valuation as a proxy for operating profitability. EBITDA gives us a clearer picture of profitability when comparing companies with different capital structures. So why is it useful to use EBITDA and ignore interest, taxes, depreciation, and amortization when comparing the performance of different companies?

Difference in Interest Expense

Two companies that are otherwise similar may have different levels of debt. The company with higher debt will likely have higher interest expense and lower Net Income. Since EBITDA ignores interest expense, it is not directly affected by management’s financing decisions.

Difference in Taxes

The amount of a tax a company pays each year is determined by a wide range of factors that does not always reflect the profitability of the company since the taxes a company is subject to reflects factors like political jurisdictions, past loss carryforwards, research and development tax credits, and depreciation on capital assets to name a few.

Depreciation and Amortization

Two companies that are otherwise similar may purchase capital assets (machines, vehicles, buildings, etc.) at different times which can impact depreciation. Ignoring depreciation and amortization allows us to normalize income for these differences.

Unadjusted EBITDA is most useful in ratios to benchmark profitability, growth, credit risk, and relative valution. Popular Unadjusted EBITDA benchmark metrics include unadjusted ebitda margin, ebitda minus capex margin, unadjusted ebitda growth, and ev / ebitda.


Click the link below to download a spreadsheet with an example Unadjusted EBITDA calculation for Zynex Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-250.9 M549.1 M1.349 B2.76 B04008001,200

The chart above depicts the distribution of unadjusted ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,525 companies were considered in this analysis, and 2,428 had meaningful values. The average unadjusted ebitda of companies in the sector is 45.832 M with a standard deviation of 293.4 M.

Zynex Inc's Unadjusted EBITDA of 10.791 M ranks in the 79.1% percentile for the sector. The following table provides additional summary stats:

Unadjusted EBITDA In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,530
Included Constituents2,428
Min-304.2 M
Max2.731 B
Median-2.338 M
Mean45.832 M
Standard Deviation293.4 M

You can find companies with similar unadjusted ebitda using this stock screener.

All rights reserved. Terms Of Use